An Ethical Dilemma, Cord Blood and Regenerative Medicine: The NY Times Digs into a Case in New York
Stanford's Hank Greely weighs in
The New York Times carried a story this morning that dealt with the “booming” field of regenerative medicine and featured spinal surgery, ethical dilemmas, transparency with patients along with an umbilical cord blood product and questions about whether the product is “proven to be safe.”
The hospital involved is NewYork-Presbyterian/Weill Cornell Med…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.